Plasma Levels of Brain Natriuretic Peptide: A Potential Marker for HIV-Related Cardiomyopathy

One of the most common and life-threatening cardiovascular complications of HIV-infection is severe global left ventricular dysfunction due to primary heart muscle disease. At present, there is no single, cost-effective and reliable method of identifying the highly prevalent HIV-related cardiac dysfunction. Nonetheless, growing evidence supports the hypothesis that brain natriuretic peptide measurement has the potential to detect patients who develop HIV-related cardiomyopathy. If true, this hypothesis would have important clinical and public health implications.

[1]  R. Shannon.  SIV cardiomyopathy in non-human primates. , 2001, Trends in cardiovascular medicine.

[2]  W. Lewis.  Cardiomyopathy in AIDS: a pathophysiological perspective. , 2000, Progress in cardiovascular diseases.

[3]  K. Bailey,et al.  Clinical criteria and biochemical markers for the detection of systolic dysfunction. , 2000, Journal of cardiac failure.

[4]  M. Kotler,et al.  Cardiac manifestations of acquired immunodeficiency syndrome. , 2000, Archives of internal medicine.

[5]  Y. Yazaki,et al.  Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels. , 2000, Japanese heart journal.

[6]  I. Grupp,et al.  Cardiac Dysfunction Occurs in the HIV-1 Transgenic Mouse Treated with Zidovudine , 2000, Laboratory Investigation.

[7]  M. Simon,et al.  Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. , 2000, Circulation.

[8]  L Bordenave,et al.  Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. , 1999, The Journal of laboratory and clinical medicine.

[9]  G. Barbarini,et al.  Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. , 1998, The New England journal of medicine.

[10]  G. Barbarini,et al.  Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators. , 1998, AIDS research and human retroviruses.

[11]  V. Stone,et al.  Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[12]  H. Tunstall-Pedoe,et al.  Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.

[13]  P. Poole‐Wilson,et al.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care , 1997, The Lancet.

[14]  J. Gutkowska,et al.  Elevated levels of natriuretic peptides in lungs of hamsters with genetic cardiomyopathy , 1997, Regulatory Peptides.

[15]  R. Lederman,et al.  Cardiovascular involvement in AIDS. , 1997, Current problems in cardiology.

[16]  A. Herskowitz.  Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. , 1996, Current opinion in cardiology.

[17]  B. Gazzard,et al.  Emerging patterns of heart disease in HIV infected homosexual subjects with and without opportunistic infections; a prospective colour flow Doppler echocardiographic study. , 1994, European heart journal.

[18]  S. Factor,et al.  Myocardial risk factors other than human immunodeficiency virus infection may contribute to histologic cardiomyopathic changes in acquired immune deficiency syndrome. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[19]  D. Vlahov,et al.  Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. , 1993, The American journal of cardiology.

[20]  S. De Castro,et al.  Heart involvement in AIDS: a prospective study during various stages of the disease. , 1992, European heart journal.

[21]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[22]  M. Moroni,et al.  Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients. , 1988, European heart journal.